Lawmakers in both parties are increasingly embracing the idea of price controls on medicines – and in doing so, they’re making a losing bet. Price controls involve a fundamental tradeoff: lower prices today in exchange for less innovation tomorrow. Proponents are wagering that savings on existing medicines will outweigh the lost benefits of treatments never developed. But the opposite is true. …